T cell receptor alpha joining 22 (TRAJ22)

**T cell receptor alpha joining 22 (TRAJ22)** is one of the gene segments encoding part of the joining (J) region in the alpha chain of the T cell receptor (TCR)[3][4][5]. The TCR alpha chain is formed by somatic recombination of variable (V) and joining (J) gene segments; TRAJ22 is a specific J segment used in this process[1][3]. These joining gene segments do not encode standalone proteins or function as independent receptors but serve as essential genetic elements contributing to the diversity and antigen recognition capacity of T cell receptors through VJ recombination[1][6][3]. The presence or absence of a specific TRAJ segment (like TRAJ22) in a TCR sequence is largely a feature of genetic variation and does not correspond to a therapeutic target, drug interaction, or biomarker in its own right. **Key clarification:** TRAJ22 is not a standalone protein or receptor target, but rather a genomic segment involved in generating TCR diversity[1][3][6]. It is not considered a therapeutic target; the functional receptor is the assembled T cell receptor alpha-beta or gamma-delta dimer[2]. Any inquiry about drug interactions, biomarkers, or disease associations pertains to the entire T cell receptor complex, not the TRAJ22 joining segment alone.

Other names

TRAJ22T cell receptor AJ22TCRA-J22